MDS | Tumor

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

Max The Butterfly: Hope and Resurrection After Cancer

July 18th 2025, 5:00pm

Article

Butterflies are believed to be a symbol of resurrection and hope. This is an inspiring story about this phenomenon.

What You Can’t Do With Cancer: Talking About the Negatives

July 7th 2025, 5:26pm

Article

I’ve survived rare blood cancer for 15 years, but the lasting side effects have taken a toll — even so, I still find purpose, joy and reasons to keep going.

Breaking Down the VERIFY Trial for Patients With Polycythemia Vera

June 13th 2025, 8:00pm

Video

Dr. Aaron Gerds breaks down the outcomes of the phase 3 VERIFY trial, investigating rusfertide, for patients with polycythemia vera, a type of blood cancer.

The Invisibility of Blood Cancers to Others

June 6th 2025, 5:00pm

Article

I describe what it is like to have an “invisible” cancer.

Cancer Survivors Look Forward, Not Backward

June 2nd 2025, 5:00pm

Article

As a cancer survivor I explain the importance of looking forward to life.

Taking Charge of My Care and Advocacy Following a Cancer Diagnosis

April 24th 2025, 5:00pm

Article

After a long battle with illness and seeking many specialists, I emphasize the need to self-advocate for ongoing care following my cancer diagnosis.

Bexmarilimab Plus Vidaza Elicit Responses in Myelodysplastic Syndromes

April 16th 2025, 3:05pm

Article

Treatment with bexmarilimab and Vidaza elicited high overall response rates in both frontline and relapsed/refractory higher-risk myelodysplastic syndrome.

Sometimes Cancer is a (Welcome) Distraction

April 8th 2025, 5:00pm

Article

In an upside-down, topsy-turvy world, cancer can be a distraction for us.

EU Approves Rytelo for Transfusion-Dependent Anemia in Low-Risk MDS

March 25th 2025, 9:00pm

Article

The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome.

Looking For The Light After MDS

March 6th 2025, 6:00pm

Article

As a cancer survivor, I talk about where to look for the light when in utter darkness.